Are the Most Distressing Concerns of Patients With Inoperable Lung Cancer Adequately Assessed? A Mixed-Methods Analysis
Authors:
- Carol TishelmanCTCarol Tishelman
- Malin LövgrenMLMalin Lövgren
- Eva BrobergerEBEva Broberger
- Katarina HambergKHKatarina Hamberg
- Mirjam A.G. SprangersMSMirjam A.G. Sprangers
- 10 April 2010
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (11) , 1942-1949
Abstract
Purpose: Standardized questionnaires for patient-reported outcomes are generally composed of specified predetermined items, although other areas may also cause patients distress. We therefore studied reports of what was most distressing for 343 patients with inoperable lung cancer (LC) at six time points during the first year postdiagnosis and how these concerns were assessed by three quality-of-life and symptom questionnaires. Patients and Methods: Qualitative analysis of patients' responses to the question “What do you find most distressing at present?” generated 20 categories, with 17 under the dimensions of “bodily distress,” “life situation with LC,” and “iatrogenic distress.” Descriptive and inferential statistical analyses were conducted. Results: The majority of statements reported as most distressing related to somatic and psychosocial problems, with 26% of patients reporting an overarching form of distress instead of specific problems at some time point. Twenty-seven percent reported some facet of their contact with the health care system as causing them most distress. While 55% to 59% of concerns reported as most distressing were clearly assessed by the European Organisation for Research and Treatment for Cancer Quality of Life Questionnaire Core-30 and Lung Cancer Module instruments, the Memorial Symptom Assessment Scale, and the modified Distress Screening Tool, iatrogenic distress is not specifically targeted by any of the three instruments examined. Conclusion: Using this approach, several distressing issues were found to be commonly reported by this patient group but were not assessed by standardized questionnaires. This highlights the need to carefully consider choice of instrument in relation to study objectives and characteristics of the sample investigated and to consider complementary means of assessment in clinical practice.Keywords
This publication has 23 references indexed in Scilit:
- Do Available Questionnaires Measure the Communication Factors That Patients and Families Consider Important at End of Life?Journal of Clinical Oncology, 2008
- Symptom Prevalence, Intensity, and Distress in Patients With Inoperable Lung Cancer in Relation to Time of DeathJournal of Clinical Oncology, 2007
- Symptom and medication profiles among cancer patients attending a palliative care clinicSupportive Care in Cancer, 2007
- Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distressLung Cancer, 2007
- Symptoms in patients with lung carcinomaCancer, 2005
- Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative carePalliative Medicine, 2003
- Symptoms in Adults with Lung CancerJournal of Pain and Symptom Management, 2000
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trialsEuropean Journal of Cancer, 1994
- The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressEuropean Journal of Cancer, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993